If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Marlyn J Mayo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Biliary Liver Cirrhosis Medicine & Life Sciences
Ursodeoxycholic Acid Medicine & Life Sciences
Cholangitis Medicine & Life Sciences
Monozygotic Twins Medicine & Life Sciences
Autoimmune Hepatitis Medicine & Life Sciences
Liver Medicine & Life Sciences
Liver Diseases Medicine & Life Sciences
Epigenomics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 2446 Citations
  • 23 h-Index
  • 46 Article
  • 2 Chapter
Ursodeoxycholic Acid
Cholangitis
Transplants
Survival
Therapeutics
4 Citations (Scopus)

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

Harms, M. H., van Buuren, H. R., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K. D., Hirschfield, G. M., Parés, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Lammers, W. J., Hansen, B. E. & van der Meer, A. J., Jan 1 2019, In : Journal of Hepatology.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Transplants
Survival
Liver
12 Citations (Scopus)

Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial

Hirschfield, G. M., Chazouillères, O., Drenth, J. P., Thorburn, D., Harrison, S. A., Landis, C. S., Mayo, M. J., Muir, A. J., Trotter, J. F., Leeming, D. J., Karsdal, M. A., Jaros, M. J., Ling, L., Kim, K. H., Rossi, S. J., Somaratne, R. M., DePaoli, A. M. & Beuers, U., Jan 1 2018, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Placebos
Alkaline Phosphatase
Bile Acids and Salts
Fibrosis
19 Citations (Scopus)

Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: Risk factors and time trends in incidence and outcome

Harms, M. H., Lammers, W. J., Thorburn, D., Corpechot, C., Invernizzi, P., Janssen, H. L. A., Battezzati, P. M., Nevens, F., Lindor, K. D., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Dalekos, G. N., Bruns, T., Parés, A., Mason, A. L., Verhelst, X., Kowdley, K. V., Goet, J. C., Hirschfield, G. M. & 2 others, Hansen, B. E. & Van Buuren, H. R., Feb 1 2018, In : American Journal of Gastroenterology. 113, 2, p. 254-264 11 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Liver
Incidence
Fibrosis
10 Citations (Scopus)

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

on behalf of the GLOBAL PBC Study Group, May 1 2018, In : Hepatology. 67, 5, p. 1920-1930 11 p.

Research output: Contribution to journalArticle

Cholangitis
Natural History
Ursodeoxycholic Acid
Paris
Gastroenterology